TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Overall Feasibility of Remote Glucose Monitoring
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Gastric Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of full eradication of Barrett esophagus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Progression Free Survival (PFS) rate at 6 Months
Endpoint domain: Mortality/survival
Primary endpoint: Days of dual use abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health Care Climate Questionnaire (HCCQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pathological Response Rate (pCR or MRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Feasibility of liquid-biopsy based CGP test
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Impact of liquid-biopsy based CGP test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients requiring rescue dose of opioids
Endpoint domain: Adverse events/effects
Primary endpoint: Inappropriate use of Z-hypnotics
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of sinus conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with deaths
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with treatment-emergent SAEs and AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Salivary metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peri-implant crestal bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adherence to pharmacological treatment guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to non-pharmacological treatment guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: standardized lateral views radiographs in a neutral standing position for the lumbopelvic region
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in levels of AMH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: change of 6 minutes walk distance at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of maximal oxygen consumption (VO2max) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of frailty index at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnostic accuracy of test 3 G q-PCR capillary blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limb ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Engagement behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Disengagement behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AUDIT
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Binge Eating Disorder Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of diabetes self-management education and support sessions attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative recurrence prediction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Bowel wall inflammatory activity detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Complications detection in CD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: MIDAS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Recruitment and Participation Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Copy Number Variant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of suicide attempts in the last month
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Suicidal Ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Hair cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of the implanted bone blocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of Stromaforte
Endpoint domain: Adverse events/effects
Primary endpoint: Human papillomavirus knowledge scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 28-day Mortality Rate
Endpoint domain: Mortality/survival
Primary endpoint: Proportions of participants experiencing any treatment-emergent adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in participant's status after TSHA-102 administration as assessed by Clinical Global Impressions-Improvement (CGI-I) scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in participant's status after TSHA-102 administration as assessed by the Revised Motor Behavior Assessment (R-MBA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in participant's status after TSHA-102 administration as assessed by the Rett Syndrome Hand Function Scale (RSHFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real World Time to Next Treatment (rwTTNT1)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of collecting respiratory waveform data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Gastrointestinal emptying time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Positive Predictive Value (PPV) of the eNose for detecting confirmed BE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative Predictive Value (NPV) of the eNose for detecting confirmed BE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the eNose for detecting confirmed BE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the eNose for detecting confirmed BE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Instances of potentially unattended psilocybin-related distress
Endpoint domain: Adverse events/effects
Primary endpoint: Neurological activity variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients with complete wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Serum etonogestrel concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum ethinyl estradiol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Probing Depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Clinical Attachment Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: ASF frequency of consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Child's total sleep time as measured by actigraphy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child's subjective sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child's daytime sleepiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of CDTM+
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of CDTM+
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adoption of CAB/RPV LA
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants with a Positive Anti-tetanus Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants with a Positive Anti-meningococcal Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients with positive CCAS diagnosis (cerebellar tumor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients with positive CCAS diagnosis (non-cerebellar tumor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maslach Burnout Inventory Human Services Survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Immunoglobulin A level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Endorphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pain pressure threshold test (PPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical spine mobility test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal and gut microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Natural Killer cell (NK)-mediated cytotoxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Subjects With Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes from baseline in Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes from baseline in absolute reticulocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes from baseline in annualized rate of VOCs leading to a healthcare visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of Ki-67
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the provision of Watch antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in quality of care
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: urodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urinary ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Stroke or TIA at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Days alive at day 90 without vasoactives, invasive mechanical ventilation and renal replacement therapy
Endpoint domain: Mortality/survival
Primary endpoint: Adherence to treatment - Brief Medication Questionnaire (BMQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Missed detection rate of ≥5mm adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Shoulder isokinetic muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: neurocognitive performance for depression
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: neurocognitive performance for health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes from baseline Ideomotor apraxia test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes from baseline Standardized test for the diagnosis of a selective ideomotor apraxia deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes from baseline Ideational apraxia test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Ultrasound Tissue Characterisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core symptoms of BED
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global EDE-Q Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in [18F]PSS232 uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: gain in alveolar ridge width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy on asthma teaching scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants offered treatment after one year
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency of Spike Wave Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oral mucosal evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elevation in Average Mean Arterial Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain sensitivity for heat stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain sensitivity for cold stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain sensitivity for electrical stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain sensitivity for pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Function of the pain facilitating pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Function of the pain inhibiting pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip joint outcome score (HOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Objective hip function scoring scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Absolute Risk Reduction of oliguria events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of SLNB
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Insufflated volume equivalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective wellbeing, global life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychological wellbeing, self-perceived success in different aspects of life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: average rate of enrollment of eligible participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: fraction of participants who have completed all assessment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: summary scores and statistics of treatment engagement and acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PD change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement of dentin sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the degree of disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of subjects requiring rescue medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post procedure length of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Successful remote interrogation and programming of CIED
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Geometric Mean Titer (GMT) of Serum Respiratory Syncytial Virus Subtype A (RSV-A) and Subtype B (RSV-B) Neutralizing Antibodies at Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants with Grade 3 and Grade 4 Treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in immune matrix
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Delivery method
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: percentage of patients who could avoid colonoscopy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Well-being of the child
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decrease labor time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of days per week of time-restricted eating
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change from Baseline in Biochemical value (Albumine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Biochemical value (normalized protein catabolic rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in (Mini Nutritional Assessment-Short Form, MNA-SF)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity of shivering
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Prescriptions for SGLT-2i or GLP-1RA Medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Mean Direction Discrimination Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Mean Direction Integration Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Mean Contrast Sensitivity for Direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Mean Contrast Sensitivity for Static Orientation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: transcranial doppler ultrasonography parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Area under the concentration-time curve of midazolam, digoxin and rosuvastatin (AUC0-tz) without BI 1839100
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of midazolam, digoxin and rosuvastatin (Cmax) without BI 1839100
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of C-SMART recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Satisfaction with C-SMART intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intensity of perineal inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of plug expulsion and surgical revision
Endpoint domain: Adverse events/effects
Primary endpoint: Type and incidence of adverse events (AE) and serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change from baseline in single fiber electromyography (SFEMG) jitter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change from baseline in the linear change in performance during the six-minute walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in the linear change in performance during the arm movement test (AMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of POC HCV viral load testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Linkage to care rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Performance evaluation by senior surgeon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety/tolerability of medications
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in functional status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: MRI disease activity on treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI disease activity off treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of Care Coordination Participant
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of Care Coordination Caregiver
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CD8+ T-cells tumour infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent of Participants With Correct Responses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median Score on a Scale of Participants Responses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parenting Stress Index total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Social Anxiety Interaction Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in imaging testing interval
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Organoleptic Oral Malodor Evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural progression-free survival
Endpoint domain: Mortality/survival